Objectives-Through recent genome-wide association studies (GWAS), several groups have reported significant association between variants in the alpha 1C subunit of the L-type voltagegated calcium channel (CACNA1C) and bipolar disorder (BP) in European and EuropeanAmerican cohorts. We performed a family-based association study to determine whether CACNA1C is associated with BP in the Latino population.
Bipolar disorder (BP) is an often chronic and debilitating mental disorder affecting approximately 1-4% of the population (1, 2) . Family, twin, and adoption studies on BP have shown that there is a substantial genetic component (3, 4) , as BP has one of the highest heritability rates of all known psychiatric disorders (1) . Over the past several years, genomewide association studies (GWAS) have produced several successes in identifying genetic variants that contribute to genetically complex human disorders (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) . Recently, a few research groups have performed independent GWAS of BP (11, (17) (18) (19) (20) (21) (22) , with little overlap amongst the single-nucleotide polymorphisms (SNPs) most strongly associated with BP (23) . However, a meta-analysis of three GWAS of BP identified a SNP within the calcium channel, voltage-dependent, L-type, alpha 1C subunit (CACNA1C) gene, rs1006737, as being strongly associated with the risk of BP (21) . A subsequent meta-analysis combining data from GWAS of BP and major depressive disorder (MDD) reported two SNPs in a 10.5-kb region within the CACNA1C gene which exceeded a genome-wide significance level (rs1006737 and rs7297582) (20) .
There has been increasing evidence in recent years that alterations in calcium signaling are involved in the pathophysiology of BP (32) . The CACNA1C gene located on chromosome 12p13.3 encodes the major constituent of the brain L-type voltage-gated calcium channels that are critical to dendritic calcium influx in response to synaptic activity (33, 34) . Reports have associated SNPs in CACNA1C with an increase in grey matter density in the amygdala and hypothalamus (35) , total grey matter (36) , and brainstem volume (37) . Neuroimaging studies of healthy individuals report that the rs1006737 risk allele modulates brain function during tasks of reward and emotional processing (38, 39) , verbal fluency (40) , attention networks (41) , and episodic and prefrontal cortex (PFC) working memory (38, 42) . The CACNA1C rs1006737 polymorphism also impacts ventrolateral PFC activation during fear processing in BP carriers of the risk allele but not their unaffected relatives (43) . In addition, studies have shown that carriers of the rs1006737 variant show a pronounced effect on measures of psychosocial functioning, including significantly higher scores on tests for depression, anxiety, interpersonal sensitivity, obsessive-compulsive thoughts, and neuroticism, even in the absence of disease (44) . These studies suggest that calcium channel dysfunction may contribute in part to the genetic etiology of BP through alterations in the functional activity of brain circuitries.
Although there is mounting evidence that CACNA1C is involved in the genetic etiology of BP, the genetic studies performed to date have been almost exclusively centered on populations with European ancestry. The replication of significant GWAS findings in diverse populations is needed in order to corroborate initial findings from European studies and characterize their genetic contribution to BP in other ethnicities. In order to address this issue, we have designed a family-based association study to try and validate the GWASsignificant CACNA1C SNPs in a large set of families with Latin American (Latino) ancestry.
Materials and methods

Study samples
The sample consisted of 215 Latino pedigrees in which BP probands and extended family members were recruited from the United States (Texas, New Mexico, California), Mexico (Mexico City, Monterrey), Costa Rica, and Guatemala. Inclusion criteria required a proband with a bipolar disorder type I (BP-I) diagnosis with at least one sibling with a clinical diagnosis of BP-I or schizoaffective BP (SABP), and a minimum of two additional firstdegree relatives willing to participate. Extended pedigrees were collected when possible to include other family members with a history of affective or psychotic disorders. The sample consisted of 157 case-parent trios and 258 affected subjects with one parent genotyped. All subjects reported ancestry from Mexico or Central America. Family structure based on number of affected family members and country of origin is listed in Table 1 . Previous genetic structure analysis has shown that these populations are closely related, with high levels of admixture consisting of three major ancestral populations (Caucasian, Native American, and African) (45) .
Subjects signed Institutional Review Board (IRB)-approved written informed consent forms prior to enrolling in the study. All study participants were diagnosed using DSM-IV criteria (46) , by a best-estimation consensus procedure using the Diagnostic Interview for Genetic Studies (DIGS) (47), Family Interview for Genetic Studies (FIGS) (48) , and available psychiatric records as previously described (49) . The 215 Hispanic pedigrees under study contained 929 individuals: 466 of whom were diagnosed with BP-I and 16 of whom were diagnosed with SABP. Of the study participants with a diagnosis of BP-I or SABP, 200 were male and 282 were female.
Genotyping
DNA was isolated from lymphoblastoid cell lines established and stored for each study participant at the National Institute of Mental Health (NIMH) Center for Collaborative Genetic Studies. SNP selection covering the CACNA1C gene was based on a tagging SNP approach (r 2 ≥ 0.9) using the SNP browser ™ Software version 4.0.1 based on data from the CEU (Utah residents with ancestry from northern and western Europe) HapMap population (50) . Known CACNA1C variants rs1006737 (20, 21) and rs7297582 (20) , which reached genome-wide significance in previous meta-analysis GWAS studies, were included in the panel. Additional proximal SNPs to these known variants were chosen from the National Center for Biotechnology Information (NCBI) dbSNP (51) based on criteria that SNPs were validated and had heterozygosity > 0.4. A total of 58 SNPs were genotyped using a custom-designed Illumina GoldenGate SNP assay according to the manufacturer's protocol (Illumina, San Diego, CA), blind to subject diagnosis and characteristics.
Genetic markers failing standard quality control criteria were excluded from further analysis: missing genotype > 0.1, minor allele frequency < 0.01, and exact Hardy-Weinberg equilibrium p < 0.01. Also excluded from the analysis were individuals with a missing genotype rate > 0.1, or Mendelian errors > 2. The discrepancy rate on 2% duplicate genotyping was < 0.002. A total of 57 SNPs for 213 pedigrees (913 individuals) were retained for further statistical analysis.
Statistical analyses
Analyses of individual SNPs were completed with the Family-Based Association Test (FBAT) version 2.0.3 (52), which was used for testing association under the null hypothesis of 'no association and no linkage' using an additive genetic model. To thoroughly test the locus identified by the two individual SNPs previously reported to be in association with BP, we also identified a haplotype block which included those SNPs and analyzed the haplotypes for association. Haploview version 4.2 (53) was used to visualize linkage disequilibrium (LD) relationships between all genotyped variants (57 SNPs) within and surrounding the CACNA1C region (54) and to construct LD blocks following the D method described by Gabriel et al. (55) . Haplotype analyses were performed using the HaplotypeBased Association Testing (HBAT) assessment in the FBAT program. Haplotype-specific and global-permuted p-values were calculated for individual haplotype tests conducted under biallelic mode in haplotype FBAT, assuming an additive genetic model. In order to maximize power in the statistical analyses, permutation procedures were implemented to calculate the empirical p-values derived from 10,000 permutations. The significance level for all statistical tests was two-tailed (p < 0.05).
Power analyses were estimated using the transmission disequilibrium test (TDT) for discrete traits of the Genetic Power Calculator (http://pngu.mgh.harvard.edu/~purcell/gpc/) with = 0.05 and D of 0.9. The current family study design (n = 215) yielded an estimate of 0.65 [odds ratio (OR) = 1.75] and 0.82 (OR = 2.00) for a gene of moderate effect and a power estimate of 0.40 (OR = 1.5) and 0.10 (OR =1.15) for a gene with minor effect. We calculated that our sample had reasonable power to detect a common risk variant, but would be insufficient to detect a susceptibility locus with a minor effect as seen in genetic studies of the CACNA1C gene for BP. To make optimal use of our data, we performed haplotypebased tests to increase the power of the association study (55) .
Results
The primary aim of this study was to test to see if findings of association of SNPs rs1006737 and rs7297582 in the CACNA1C gene with BP, as reported in a European ancestry cohort by Liu et al. (20) , were valid in other populations, specifically in the Latino population. When tested individually, we found no significant association between these two SNPs and BP (rs7297582, Z = 0.306, p = 0.760; rs1006737, Z = 0.725, p = 0.469) in the Latino population studied.
Given the negative findings of association for SNPs rs1006737 and rs7297582, we wished to test whether SNPs in LD with these variants would associate with BP in our Latino cohort. We used a tagged-SNP approach to cover the CACNA1C gene in addition to several SNPs in close proximity to rs1006737 and rs7297582, assuming that these SNPs were not functional SNPs but rather variants in LD with true causal mutation. Twelve LD blocks were identified in our sample (Fig. 1) . Haploblock 4 encompasses both rs1006737 and rs7297582 SNPs, previously shown to associate with BP. Allele frequencies and the results of FBAT for single SNP analysis for the eight SNPs comprising Haploblock 4 are shown in Table 2 . Univariate (single-marker) FBAT demonstrated no preferential transmission for any of the variant alleles tested (Table 2) .
Since the use of haplotypes may provide greater statistical power in association studies of common genetic variation than can be obtained with individual SNPs (55), we conducted haplotype analyses focusing on Haploblock 4 which contained SNPs previously associated with BP. To determine whether any specific haplotype would confer a higher risk for BP, the specific and global-haplotype FBAT tests of association were performed. One common and three rare haplotypes displayed significant association under an additive model ( Table  3 ). The p-values of the whole haplotype permutation test were also statistically significant ( 2 sum, p = 0.0018) ( Table 3) . Of note, among these four disease-associated haplotypes, three (GGGCGGGA, GGGCGAGA, and AAAGAGGA) showed protective effect with negative Z-scores and one showed a susceptibility effect with a positive Z-score (GAAGGAAG). Interestingly, the specific alleles previously shown to be associated with BP on SNPs rs1006737 (A) and rs7297582 (A), were also seen on the GAAGGAAG haplotype showing increased risk (Z = 2.236, p = 0.031). The common haplotype significantly associated with BP was present across all countries in our cohort, while the other three haplotypes were very rare.
Discussion
In the present study, we attempted to validate, in nearly 1,000 Latinos, the significant CACNA1C variants associated with BP identified in populations of predominantly European ancestry (11, 18, 20, 21) . When analyzed individually, we were unable to replicate association of SNPs rs7297582 and rs1006737 with BP in the Latino population. However, these two previously identified SNPs have not been shown to be functionally significant within the CACNA1C gene and may only be in LD with functional variants at this locus.
Moreover, allele frequencies of genotyped markers in strong LD with the two previously associated SNPs are highly variable across ancestral populations (hapmap.ncbi.nlm.nih.gov), suggesting the likelihood of a differential profile of CACNA1C variants with ethnicity (Table 4) . Given the negative findings of our single locus tests compared to previous associations found in the Caucasian population, combined with the finding that haplotypes at this locus are associated with BP in the Latino population, the possibility remains that there might be additional functional variants in both the European and Latino ancestry populations that might still be in strong LD with rs7297582 and rs1006737.
It is known that in the presence of multiple tightly linked markers a haplotype test may be more powerful to detect association than corresponding single-locus tests (56) . Haplotypebased analysis of the haploblock encompassing the two previously reported SNPs associated with BP provided significant evidence for association with BP in the Latino population. Our complementary LD block-based analysis revealed that an eight-locus haploblock (consisting of rs769087, rs1006737, rs2159100, rs4765905, rs2370413, rs7297582, rs758170, and rs1860002) provided stronger evidence of association than single-marker analysis. In affected individuals, three distinct haplotypes (GGGCGGGA, GGGCGAGA, and AAAGAGGA) were under-represented and one haplotype (GAAGGAAG) was overrepresented, giving rise to a significant permutated whole marker haplotypic association ( 2 sum, p = 0.0018). We performed a conditional analysis to see if the association was driven by the two previously reported risk variants. We removed the two variants and performed the family-based haplotype association test with the remaining six variants under identical parameters outlined in the methods section. These results were very similar to our initial findings, in which one common and three rare haplotypes were significantly associated (see Supplementary Table 1 ). The whole marker permutation test was also significant, indicating that the association is not driven by these two previously reported SNPs.
Since the fruition of this study, The Psychiatric GWAS Consortium (PGC) BP Working Group published their results of the most comprehensive GWAS of BP to date, including 16,731 samples and a replication sample of 46,918 individuals. They report a genome-wide significant SNP, rs4765913, in CACNA1C associated with BP (57) . A combined analysis of PGC BP and PGC schizophrenia showed stronger association of this SNP compared to the BP GWAS alone (26, 57) . The PGC significant variant falls between two haploblocks identified in our Latino population (Fig. 2) . This SNP is approximately 6 kb downstream from the proximal marker of the associated haploblock and approximately 16 kb upstream of the next closest marker. Although we did not test SNP rs4765913 directly, we believe it is very likely, due to its proximity, to be in strong LD with the haploblock associated with BP in our Latino cohort, thus providing additional support for our findings.
Another recently published study reported a significant association of rs4765905 located within CACNA1C with BP and schizophrenic patients (n = 16,373) compared to control subjects (n = 14,044) (27) . SNP rs4765905 was also genotyped in our current study and is nested in the LD block used in this association study. Taken as a whole, these results provide compelling evidence that this region of the CACNA1C gene plays a role in the pathogenesis of BP.
There are several limitations of the present study. First, compared to the previous studies in European ancestry populations, this was a smaller sample size. Larger sample sizes might be required in order to detect statistically significant association for single, common alleles in the Latino population. Secondly, this study only utilized published SNPs and did not use a sequencing approach to detect other potential SNPs or genetic variants within the gene which might be more directly causal for the disease. Finally, the combination of families from several countries may introduce heterogeneity into the analysis. However, if that were to be the case, this would diminish the chances of identifying association of gene variants. There are also some strengths to the present study: family-based association analyses were used, which prevent potential false positive results due to stratification in case-control analyses, and a narrow phenotype of carefully diagnosed BP-I and SABP cases were utilized as the affected phenotype of interest, drawn from families with multiplex BP cases.
In conclusion, these results provide the first evidence that genetic variations in CACNA1C might play a role in the pathogenesis of BP in the Latino population. We provide further support to previous case-control studies in Caucasian populations, strengthening the notion that genetic variation of CACNA1C influences the susceptibility to BP. Further investigations of the CACNA1C gene are thus warranted to increase our understanding of its role in the pathogenesis of BP. Careful replication with appropriate designs in independent sample sets from the Latino population is needed as advocated for stringent confirmation of genetic associations. Furthermore, comprehensive fine-mapping and resequencing will be required to characterize the disease gene architecture of this region in the Latino population.
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